EMA Authorised: Trimbow (beclometasone dipropionate;formoterol fumarate dihydrate;glycopyrronium bromide) — Chiesi Farmaceutici S.p.A.

View source ↗

Summary

EMA authorised Trimbow (beclometasone dipropionate; formoterol fumarate dihydrate; glycopyrronium bromide) for chronic obstructive pulmonary disease.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Obstructive Pulmonary Disease

Drugs mentioned

• Trimbow (budesonide/formoterol/glycopyrronium)

Snippet

Status: Authorised. Therapeutic area: Pulmonary Disease, Chronic Obstructive. MAH: Chiesi Farmaceutici S.p.A.. Decision date: 25/06/2026